Work

Abstract P2-12-23: A phase 2 trial combining tiragolumab and atezolizumab with neoadjuvant or first line chemotherapy for triple negative breast cancer (SKYLINE)

Year: 2025

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs24-p2-12-23

Authors: Francois-Clement Bidard, Romain-David Seban, Laurence Champion, Nina Jehanno, Anne Vincent-Salomon, Irene Buvat, Julien Fouque, Toulsie Ramtohul, Agathe Peltier, Diana Bello-Roufai, Florence Coussy, Fatima Mechta-Grigoriou

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411285876

Cites:

Cited by:

Related to: 10